NCT02000427 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 45
- units
- Participants
- groups
- description
- Participants received blinatumomab by continuous intravenous (CIV) infusion over 4 weeks followed by a treatment-free interval of 2 weeks for 2 cycles. Participants who achieved a complete remission or complete remission with partial or incomplete hematologic recovery within 2 induction cycles of treatment could receive up to 3 additional consolidation cycles of blinatumomab. The initial dose was 9 μg/day for the first 7 days of treatment, increased to 28 μg/day starting on day 8 and for all subsequent cycles of treatment.
- id
- BG000
- title
- Blinatumomab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.0
- value
- 52.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- 18 to < 35 years
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- 35 to < 55 years
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- 55 to < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- ≥ 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 24
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 43
- title
- Not Hispanic/Latino
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 1 TKI
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- 2 TKIs
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- 3 TKIs
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- 4 TKIs
- param Type
- NUMBER
- title
- Prior Tyrosine Kinase Inhibitor (TKI) Treatment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No relapses
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- 1 relapse
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- 2 relapses
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- ≥ 3 relapses
- param Type
- NUMBER
- title
- Number of Prior Relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- 0 regimens
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- 1 regimen
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- 2 regimens
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- ≥ 3 regimens
- param Type
- NUMBER
- title
- Number of Prior Salvage Regimens
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- No
- param Type
- NUMBER
- title
- Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 26.1
- value
- 27.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time From Initial Diagnosis
- unit Of Measure
- months
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 45
- units
- Participants
- groups
- description
- Participants received blinatumomab by continuous intravenous (CIV) infusion over 4 weeks followed by a treatment-free interval of 2 weeks for 2 cycles. Participants who achieved a complete remission or complete remission with partial or incomplete hematologic recovery within 2 induction cycles of treatment could receive up to 3 additional consolidation cycles of blinatumomab. The initial dose was 9 μg/day for the first 7 days of treatment, increased to 28 μg/day starting on day 8 and for all subsequent cycles of treatment.
- id
- BG000
- title
- Blinatumomab
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.0
- value
- 52.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- 18 to < 35 years
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- 35 to < 55 years
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- 55 to < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- ≥ 65 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 24
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 43
- title
- Not Hispanic/Latino
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 1 TKI
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- 2 TKIs
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- 3 TKIs
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- 4 TKIs
- param Type
- NUMBER
- title
- Prior Tyrosine Kinase Inhibitor (TKI) Treatment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No relapses
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- 1 relapse
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- 2 relapses
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- ≥ 3 relapses
- param Type
- NUMBER
- title
- Number of Prior Relapses
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- 0 regimens
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- 1 regimen
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- 2 regimens
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- ≥ 3 regimens
- param Type
- NUMBER
- title
- Number of Prior Salvage Regimens
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- No
- param Type
- NUMBER
- title
- Prior Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 26.1
- value
- 27.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time From Initial Diagnosis
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle